CIK 0001160308 · Non-accelerated filer<br>Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841318182
- Phone
- 51285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-14 | Hawkins Richard J Director | Option exercise | +5,860 | $1.46 | $9K | 121,326 |
| 2025-11-14 | Hawkins Richard J Director | Option exercise · Stock Option (Right to Buy) | −5,860 | 0 | ||
| 2025-10-20 | Wasfi Yasmine Chief Medical Officer | Grant or award | +35,000 | 190,000 | ||
| 2025-10-20 | Wasfi Yasmine Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2025-06-20 | Hawkins Richard J Director | Purchase | +48,225 | $2.04 | $99K | 115,466 |
| 2025-05-29 | McCracken Joseph S Director | Purchase | +10,000 | $2.08 | $21K | 260,837 |
| 2025-03-31 | RAMSAY DAVID A Director | Purchase | +150,000 | $2.78 | $416K | 2,513,642 |
| 2025-02-13 | Lutz Robert Matthew Chief Operating Officer | Shares withheld for taxes | −38,263 | $2.83 | $108K | 361,737 |
| 2024-12-16 | Lowrance David L Chief Financial Officer | Sale | −25,000 | $3.33 | $83K | 381,005 |
| 2024-12-16 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Sale | −54,702 | $3.31 | $181K | 1,536,379 |
| 2024-12-16 | Hawkins Richard J Director | Sale | −8,000 | $3.32 | $27K | 67,241 |
| 2024-12-13 | Erickson Anne Chief Business Officer | Shares withheld for taxes | −18,263 | $3.21 | $59K | 434,672 |
| 2024-12-13 | Lowrance David L Chief Financial Officer | Gift | −12,000 | 430,355 | ||
| 2024-12-13 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −24,350 | $3.21 | $78K | 406,005 |
| 2024-12-13 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −92,593 | $3.21 | $297K | 1,591,081 |
| 2024-12-12 | Erickson Anne Chief Business Officer | Grant or award | +100,000 | 452,935 | ||
| 2024-12-12 | Erickson Anne Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2024-12-12 | Parker Braden C. Chief Commercial Officer | Grant or award | +20,000 | 105,000 | ||
| 2024-12-12 | Parker Braden C. Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2024-12-12 | Lutz Robert Matthew Chief Operating Officer | Grant or award | +100,000 | 400,000 |
Page 4 of 11 · 202 trades